(Q50679640)

17 March 2018

title

Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors (English)

1 reference

17 March 2018

1 reference

17 March 2018

author name string

Tine Gregersen

1 reference

17 March 2018

Jonas Worsøe

1 reference

17 March 2018

Vincent Schlageter

1 reference

17 March 2018

Søren Laurberg

1 reference

17 March 2018

Klaus Krogh

1 reference

17 March 2018

publication date

30 May 2011

1 reference

17 March 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

17 March 2018

volume

1 reference

17 March 2018

issue

7-8

1 reference

17 March 2018

page(s)

895-902

1 reference

17 March 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Neuroendocrine tumors of the diffuse neuroendocrine system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Small intestinal neuroendocrine tumors: prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Current status of gastrointestinal carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Magnetic pill tracking: a novel non-invasive tool for investigation of human digestive motility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Effect of 5‐hydroxytryptamine on gastrointestinal motility in conscious guinea‐pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Evidence for a 5-HT4 receptor pathway mediating chloride secretion in the rat distal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Effect of MKC-733, a 5-HT receptor partial agonist, on bowel motility and symptoms in subjects with constipation: an exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

Normal colon transit time in healthy Chinese adults in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2011.579157

10.3109/00365521.2011.579157

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

release_tqiagfmlmjg47bivzzlhe6sesi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tqiagfmlmjg47bivzzlhe6sesi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 March 2018